{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:48:27Z","timestamp":1793166507864,"version":"4.5.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000066","name":"U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R00ES031050"],"award-info":[{"award-number":["R00ES031050"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sheldon D. Murphy Endowed Chair in Toxicology and Environmental Health","id":[{"id":"https:\/\/ror.org\/0590fg074","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"DOI":"10.1038\/s41380-026-03922-8","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:18:16Z","timestamp":1791670696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Zebrafish behavioral phenomics reveals functional subtypes of autism risk genes"],"prefix":"10.1038","author":[{"given":"Karl","family":"Stuntzner-Gibson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baixi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4667-891X","authenticated-orcid":false,"given":"Yijie","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"key":"3922_CR1","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41588-022-01104-0","volume":"54","author":"JM Fu","year":"2022","unstructured":"Fu JM, Satterstrom FK, Peng M, Brand H, Collins RL, Dong S, et al. Rare coding variation provides insight into the genetic architecture and phenotypic context of autism. Nat Genet. 2022;54:1320\u201331.","journal-title":"Nat Genet"},{"key":"3922_CR2","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.cell.2019.12.036","volume":"180","author":"FK Satterstrom","year":"2020","unstructured":"Satterstrom FK, Kosmicki JA, Wang J, Breen MS, De Rubeis S, An JY, et al. Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism. Cell. 2020;180:568\u201384.e523.","journal-title":"Cell"},{"key":"3922_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.psc.2009.12.002","volume":"33","author":"P El-Fishawy","year":"2010","unstructured":"El-Fishawy P, State MW. The genetics of autism: key issues, recent findings, and clinical implications. Psychiatr Clin North Am. 2010;33:83\u2013105.","journal-title":"Psychiatr Clin North Am"},{"key":"3922_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3389\/fncel.2019.00385","volume":"13","author":"L Rylaarsdam","year":"2019","unstructured":"Rylaarsdam L, Guemez-Gamboa A. Genetic causes and modifiers of autism spectrum disorder. Front Cell Neurosci. 2019;13:385.","journal-title":"Front Cell Neurosci"},{"key":"3922_CR5","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41593-023-01259-x","volume":"26","author":"AM Buch","year":"2023","unstructured":"Buch AM, Vertes PE, Seidlitz J, Kim SH, Grosenick L, Liston C. Molecular and network-level mechanisms explaining individual differences in autism spectrum disorder. Nat Neurosci. 2023;26:650\u201363.","journal-title":"Nat Neurosci"},{"key":"3922_CR6","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.56257","volume":"11","author":"SGW Urchs","year":"2022","unstructured":"Urchs SGW, Tam A, Orban P, Moreau C, Benhajali Y, Nguyen HD, et al. Functional connectivity subtypes associate robustly with ASD diagnosis. Elife. 2022;11:e56257.","journal-title":"Elife"},{"key":"3922_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.biopsych.2020.03.022","volume":"88","author":"SJ Hong","year":"2020","unstructured":"Hong SJ, Vogelstein JT, Gozzi A, Bernhardt BC, Yeo BTT, Milham MP, et al. Toward neurosubtypes in autism. Biol Psychiatry. 2020;88:111\u201328.","journal-title":"Biol Psychiatry"},{"key":"3922_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2025.103736","volume":"45","author":"LB Norbom","year":"2025","unstructured":"Norbom LB, Syed B, Kjelkenes R, Rokicki J, Beauchamp A, Nerland S, et al. Probing autism and ADHD subtypes using cortical signatures of the T1w\/T2w-ratio and morphometry. Neuroimage Clin. 2025;45:103736.","journal-title":"Neuroimage Clin"},{"key":"3922_CR9","doi-asserted-by":"publisher","unstructured":"Zahiri J, Mirzaie M, Duan K, Xiao Y, Aamodt C, Yang X et al. Beyond the spectrum: subtype-specific molecular insights into autism spectrum disorder via multimodal data integration. medRxiv:2024.09.17.24313857 [Preprint]. 2024. Available from: https:\/\/doi.org\/10.1101\/2024.09.17.24313857","DOI":"10.1101\/2024.09.17.24313857"},{"key":"3922_CR10","doi-asserted-by":"publisher","unstructured":"Naveed S, Dmytriw AA, Ghozy A, Morsy S. Genetic networks suggest Asperger\u2019s syndrome as a distinct subtype of autism spectrum disorders. Research in Autism Spectrum Disorders. 2024;118. https:\/\/doi.org\/10.1016\/j.rasd.2024.102484.","DOI":"10.1016\/j.rasd.2024.102484"},{"key":"3922_CR11","doi-asserted-by":"publisher","first-page":"578972","DOI":"10.3389\/fneur.2020.578972","volume":"11","author":"VW Hu","year":"2020","unstructured":"Hu VW, Bi C. Phenotypic subtyping and Re-analyses of existing transcriptomic data from autistic probands in simplex families reveal differentially expressed and ASD trait-associated genes. Front Neurol. 2020;11:578972.","journal-title":"Front Neurol"},{"key":"3922_CR12","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1038\/s41588-025-02224-z","volume":"57","author":"A Litman","year":"2025","unstructured":"Litman A, Sauerwald N, Green Snyder L, Foss-Feig J, Park CY, Hao Y, et al. Decomposition of phenotypic heterogeneity in autism reveals underlying genetic programs. Nat Genet. 2025;57:1611\u20139.","journal-title":"Nat Genet"},{"key":"3922_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18526-1","volume":"11","author":"G Ramaswami","year":"2020","unstructured":"Ramaswami G, Won H, Gandal MJ, Haney J, Wang JC, Wong CCY, et al. Integrative genomics identifies a convergent molecular subtype that links epigenomic with transcriptomic differences in autism. Nat Commun. 2020;11:4873.","journal-title":"Nat Commun"},{"key":"3922_CR14","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1017\/S0954579420000784","volume":"32","author":"S Trinh","year":"2020","unstructured":"Trinh S, Arnett A, Kurtz-Nelson E, Beighley J, Picoto M, Bernier R. Transcriptional subtyping explains phenotypic variability in genetic subtypes of autism spectrum disorder. Dev Psychopathol. 2020;32:1353\u201361.","journal-title":"Dev Psychopathol"},{"key":"3922_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-023-05278-0","volume":"24","author":"J Zhang","year":"2023","unstructured":"Zhang J, Ji G, Gao X, Guan J. Single-nucleus gene and gene set expression-based similarity network fusion identifies autism molecular subtypes. BMC Bioinformatics. 2023;24:142.","journal-title":"BMC Bioinformatics"},{"key":"3922_CR16","doi-asserted-by":"publisher","unstructured":"Jiang H, Rodriguez-Cruces R, Xie K, Kebets V, Wang Y, Weber CF et al. Three subtypes of autism spectrum disorder with transcriptomic signatures derived from morphometric similarity networks. bioRxiv. 2024. Available from: https:\/\/doi.org\/10.1101\/2024.09.06.611561.","DOI":"10.1101\/2024.09.06.611561"},{"key":"3922_CR17","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.039446","volume":"12","author":"Y Geng","year":"2019","unstructured":"Geng Y, Peterson RT. The zebrafish subcortical social brain as a model for studying social behavior disorders. Dis Model Mech. 2019;12:dmm039446.","journal-title":"Dis Model Mech"},{"key":"3922_CR18","doi-asserted-by":"publisher","first-page":"100381","DOI":"10.1016\/j.crmeth.2022.100381","volume":"3","author":"Y Geng","year":"2023","unstructured":"Geng Y, Yates C, Peterson RT. Social behavioral profiling by unsupervised deep learning reveals a stimulative effect of dopamine D3 agonists on zebrafish sociality. Cell Rep Methods. 2023;3:100381.","journal-title":"Cell Rep Methods"},{"key":"3922_CR19","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.neuron.2015.12.039","volume":"89","author":"EJ Hoffman","year":"2016","unstructured":"Hoffman EJ, Turner KJ, Fernandez JM, Cifuentes D, Ghosh M, Ijaz S, et al. Estrogens suppress a behavioral phenotype in zebrafish mutants of the autism risk gene, CNTNAP2. Neuron. 2016;89:725\u201333.","journal-title":"Neuron"},{"key":"3922_CR20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2518846123","volume":"123","author":"P Jamadagni","year":"2026","unstructured":"Jamadagni P, Dai Y, Liu Y, Weinschutz Mendes H, Pruitt A, Khan S, et al. Pharmaco-behavioral profiling identifies suppressors of autism gene-associated phenotypes in zebrafish. Proc Natl Acad Sci USA 2026;123:e2518846123.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3922_CR21","doi-asserted-by":"publisher","unstructured":"Diaz L, Kong AX, Zhang P, Chi J, Pham K, Johnson M et al. Butyrate rescues chlorpyrifos-induced social deficits through inhibition of class I histone deacetylases. bioRxiv:2025.10.19.683261 [Preprint]. 2025. Available from: https:\/\/doi.org\/10.1101\/2025.10.19.683261.","DOI":"10.1101\/2025.10.19.683261"},{"key":"3922_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm7069","volume":"8","author":"Y Geng","year":"2022","unstructured":"Geng Y, Zhang T, Alonzo IG, Godar SC, Yates C, Pluimer BR, et al. Top2a promotes the development of social behavior via PRC2 and H3K27me3. Sci Adv. 2022;8:eabm7069.","journal-title":"Sci Adv"},{"key":"3922_CR23","doi-asserted-by":"publisher","unstructured":"Kong AX, Johnson M, Eno AF, Pham K, Zhang P, Geng Y. Proteome-wide reverse molecular docking reveals folic acid receptor as a mediator of PFAS-induced neurodevelopmental toxicity. bioRxiv:2024.11.11.623082 [Preprint]. 2024. Available from: https:\/\/doi.org\/10.1101\/2024.11.11.623082.","DOI":"10.1101\/2024.11.11.623082"},{"key":"3922_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nchembio.2097","volume":"12","author":"G Bruni","year":"2016","unstructured":"Bruni G, Rennekamp AJ, Velenich A, McCarroll M, Gendelev L, Fertsch E, et al. Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds. Nat Chem Biol. 2016;12:559\u201366.","journal-title":"Nat Chem Biol"},{"key":"3922_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54375-y","volume":"15","author":"L Gendelev","year":"2024","unstructured":"Gendelev L, Taylor J, Myers-Turnbull D, Chen S, McCarroll MN, Arkin MR, et al. Deep phenotypic profiling of neuroactive drugs in larval zebrafish. Nat Commun. 2024;15:9955.","journal-title":"Nat Commun"},{"key":"3922_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aav1966","volume":"4","author":"J Jordi","year":"2018","unstructured":"Jordi J, Guggiana-Nilo D, Bolton AD, Prabha S, Ballotti K, Herrera K, et al. High-throughput screening for selective appetite modulators: a multibehavioral and translational drug discovery strategy. Sci Adv. 2018;4:eaav1966.","journal-title":"Sci Adv"},{"key":"3922_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nchembio.307","volume":"6","author":"D Kokel","year":"2010","unstructured":"Kokel D, Bryan J, Laggner C, White R, Cheung CY, Mateus R, et al. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol. 2010;6:231\u20137.","journal-title":"Nat Chem Biol"},{"key":"3922_CR28","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nchembio.2089","volume":"12","author":"AJ Rennekamp","year":"2016","unstructured":"Rennekamp AJ, Huang XP, Wang Y, Patel S, Lorello PJ, Cade L, et al. Sigma-1 receptor ligands control a switch between passive and active threat responses. Nat Chem Biol. 2016;12:552\u20138.","journal-title":"Nat Chem Biol"},{"key":"3922_CR29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1126\/science.1183090","volume":"327","author":"J Rihel","year":"2010","unstructured":"Rihel J, Prober DA, Arvanites A, Lam K, Zimmerman S, Jang S, et al. Zebrafish behavioral profiling links drugs to biological targets and rest\/wake regulation. Science. 2010;327:348\u201351.","journal-title":"Science"},{"key":"3922_CR30","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1534\/g3.119.401035","volume":"10","author":"BH Kim","year":"2020","unstructured":"Kim BH, Zhang G. Generating stable knockout zebrafish lines by deleting large chromosomal fragments using multiple gRNAs. G3 (Bethesda). 2020;10:1029\u201337.","journal-title":"G3 (Bethesda)"},{"key":"3922_CR31","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.59683","volume":"10","author":"F Kroll","year":"2021","unstructured":"Kroll F, Powell GT, Ghosh M, Gestri G, Antinucci P, Hearn TJ, et al. A simple and effective F0 knockout method for rapid screening of behaviour and other complex phenotypes. Elife. 2021;10:e59683.","journal-title":"Elife"},{"key":"3922_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.devcel.2018.06.003","volume":"46","author":"RS Wu","year":"2018","unstructured":"Wu RS, Lam II, Clay H, Duong DN, Deo RC, Coughlin SR. A rapid method for directed gene knockout for screening in G0 zebrafish. Dev Cell. 2018;46:112\u201325.e114.","journal-title":"Dev Cell"},{"key":"3922_CR33","doi-asserted-by":"publisher","first-page":"e0230566","DOI":"10.1371\/journal.pone.0230566","volume":"15","author":"E Buglo","year":"2020","unstructured":"Buglo E, Sarmiento E, Martuscelli NB, Sant DW, Danzi MC, Abrams AJ, et al. Genetic compensation in a stable slc25a46 mutant zebrafish: a case for using F0 CRISPR mutagenesis to study phenotypes caused by inherited disease. PLoS One. 2020;15:e0230566.","journal-title":"PLoS One"},{"key":"3922_CR34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ridd.2005.03.003","volume":"27","author":"KS Lam","year":"2006","unstructured":"Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil. 2006;27:254\u201389.","journal-title":"Res Dev Disabil"},{"key":"3922_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/brainsci10030163","volume":"10","author":"R Marotta","year":"2020","unstructured":"Marotta R, Risoleo MC, Messina G, Parisi L, Carotenuto M, Vetri L, et al. The neurochemistry of autism. Brain Sci. 2020;10:163.","journal-title":"Brain Sci"},{"key":"3922_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaacop.2024.01.010","volume":"3","author":"H Martin","year":"2025","unstructured":"Martin H, Choi JE, Rodrigues AR, Eshel N. Review: dopamine, serotonin, and the translational neuroscience of aggression in autism spectrum disorder. JAACAP Open. 2025;3:29\u201341.","journal-title":"JAACAP Open"},{"key":"3922_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroscience.2015.11.010","volume":"321","author":"CL Muller","year":"2016","unstructured":"Muller CL, Anacker AMJ, Veenstra-VanderWeele J. The serotonin system in autism spectrum disorder: from biomarker to animal models. Neuroscience. 2016;321:24\u201341.","journal-title":"Neuroscience"},{"key":"3922_CR38","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s00259-025-07620-5","volume":"53","author":"T Noppari","year":"2026","unstructured":"Noppari T, Tuisku J, Lukkarinen L, Tani P, Lindberg N, Saure E, et al. Aberrant type 2 dopamine and mu-opioid receptor availability in autism spectrum disorder. Eur J Nucl Med Mol Imaging. 2026;53:2069\u201382.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3922_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-019-0275-3","volume":"10","author":"A Abu-Akel","year":"2019","unstructured":"Abu-Akel A, Allison C, Baron-Cohen S, Heinke D. The distribution of autistic traits across the autism spectrum: evidence for discontinuous dimensional subpopulations underlying the autism continuum. Mol Autism. 2019;10:24.","journal-title":"Mol Autism"},{"key":"3922_CR40","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1469-7610.2012.02588.x","volume":"54","author":"S Georgiades","year":"2013","unstructured":"Georgiades S, Szatmari P, Boyle M, Hanna S, Duku E, Zwaigenbaum L, et al. Investigating phenotypic heterogeneity in children with autism spectrum disorder: a factor mixture modeling approach. J Child Psychol Psychiatry. 2013;54:206\u201315.","journal-title":"J Child Psychol Psychiatry"},{"key":"3922_CR41","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/aur.3151","volume":"17","author":"M Pizzano","year":"2024","unstructured":"Pizzano M, Shire S, Shih W, Levato L, Landa R, Lord C, et al. Profiles of minimally verbal autistic children: Illuminating the neglected end of the spectrum. Autism Res. 2024;17:1218\u201329.","journal-title":"Autism Res"},{"key":"3922_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-020-00367-w","volume":"11","author":"J Tillmann","year":"2020","unstructured":"Tillmann J, Uljarevic M, Crawley D, Dumas G, Loth E, Murphy D, et al. Dissecting the phenotypic heterogeneity in sensory features in autism spectrum disorder: a factor mixture modelling approach. Mol Autism. 2020;11:67.","journal-title":"Mol Autism"},{"key":"3922_CR43","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1177\/1362361318815645","volume":"23","author":"B Tomaszewski","year":"2019","unstructured":"Tomaszewski B, Smith DaWalt L, Odom SL. Growth mixture models of adaptive behavior in adolescents with autism spectrum disorder. Autism. 2019;23:1472\u201384.","journal-title":"Autism"},{"key":"3922_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/science.aab3897","volume":"350","author":"M Sahin","year":"2015","unstructured":"Sahin M, Sur M. Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders. Science. 2015;350:aab3897.","journal-title":"Science"},{"key":"3922_CR45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cell.2014.06.017","volume":"158","author":"R Bernier","year":"2014","unstructured":"Bernier R, Golzio C, Xiong B, Stessman HA, Coe BP, Penn O, et al. Disruptive CHD8 mutations define a subtype of autism early in development. Cell. 2014;158:263\u201376.","journal-title":"Cell"},{"key":"3922_CR46","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ejhg.2012.175","volume":"21","author":"L Boccuto","year":"2013","unstructured":"Boccuto L, Lauri M, Sarasua SM, Skinner CD, Buccella D, Dwivedi A, et al. Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders. Eur J Hum Genet. 2013;21:310\u20136.","journal-title":"Eur J Hum Genet"},{"key":"3922_CR47","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.3390\/jcm14113790","volume":"14","author":"N DiStefano","year":"2025","unstructured":"DiStefano N, Cooper JN, Elisha DH, Zalta M, Mittal J, Cohen D, et al. Decoding SCN2A variants: bridging genetics and phenotypes in autism spectrum disorder. J Clin Med. 2025;14:3790.","journal-title":"J Clin Med"},{"key":"3922_CR48","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1523\/JNEUROSCI.0420-19.2020","volume":"40","author":"TR Gamache","year":"2020","unstructured":"Gamache TR, Araki Y, Huganir RL. Twenty years of SynGAP research: from synapses to cognition. J Neurosci. 2020;40:1596\u2013605.","journal-title":"J Neurosci"},{"key":"3922_CR49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrn.2016.183","volume":"18","author":"P Monteiro","year":"2017","unstructured":"Monteiro P, Feng G. SHANK proteins: roles at the synapse and in autism spectrum disorder. Nat Rev Neurosci. 2017;18:147\u201357.","journal-title":"Nat Rev Neurosci"},{"key":"3922_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa170","volume":"2","author":"K Goodspeed","year":"2020","unstructured":"Goodspeed K, Perez-Palma E, Iqbal S, Cooper D, Scimemi A, Johannesen KM, et al. Current knowledge of SLC6A1-related neurodevelopmental disorders. Brain Commun. 2020;2:fcaa170.","journal-title":"Brain Commun"},{"key":"3922_CR51","doi-asserted-by":"publisher","first-page":"1090865","DOI":"10.3389\/fnsyn.2022.1090865","volume":"14","author":"SL Sabo","year":"2022","unstructured":"Sabo SL, Lahr JM, Offer M, Weekes A, Sceniak MP. GRIN2B-related neurodevelopmental disorder: current understanding of pathophysiological mechanisms. Front Synaptic Neurosci. 2022;14:1090865.","journal-title":"Front Synaptic Neurosci"},{"key":"3922_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-023-01450-8","volume":"15","author":"CP D\u2019Incal","year":"2023","unstructured":"D\u2019Incal CP, Van Rossem KE, De Man K, Konings A, Van Dijck A, Rizzuti L, et al. Chromatin remodeler Activity-Dependent Neuroprotective Protein (ADNP) contributes to syndromic autism. Clin Epigenetics. 2023;15:45.","journal-title":"Clin Epigenetics"},{"key":"3922_CR53","doi-asserted-by":"publisher","first-page":"e375","DOI":"10.1002\/wdev.375","volume":"9","author":"M Co","year":"2020","unstructured":"Co M, Anderson AG, Konopka G. FOXP transcription factors in vertebrate brain development, function, and disorders. Wiley Interdiscip Rev Dev Biol. 2020;9:e375.","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"key":"3922_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110089","volume":"37","author":"E Markenscoff-Papadimitriou","year":"2021","unstructured":"Markenscoff-Papadimitriou E, Binyameen F, Whalen S, Price J, Lim K, Ypsilanti AR, et al. Autism risk gene POGZ promotes chromatin accessibility and expression of clustered synaptic genes. Cell Rep. 2021;37:110089.","journal-title":"Cell Rep"},{"key":"3922_CR55","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/ncb2075","volume":"12","author":"RS Nozawa","year":"2010","unstructured":"Nozawa RS, Nagao K, Masuda HT, Iwasaki O, Hirota T, Nozaki N, et al. Human POGZ modulates dissociation of HP1alpha from mitotic chromosome arms through Aurora B activation. Nat Cell Biol. 2010;12:719\u201327.","journal-title":"Nat Cell Biol"},{"key":"3922_CR56","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a036780","volume":"9","author":"S Rademacher","year":"2019","unstructured":"Rademacher S, Eickholt BJ. PTEN in autism and neurodevelopmental disorders. Cold Spring Harb Perspect Med. 2019;9:a036780.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3922_CR57","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3389\/fnins.2015.00477","volume":"9","author":"RA Barnard","year":"2015","unstructured":"Barnard RA, Pomaville MB, O\u2019Roak BJ. Mutations and modeling of the chromatin remodeler CHD8 define an emerging autism etiology. Front Neurosci. 2015;9:477.","journal-title":"Front Neurosci"},{"key":"3922_CR58","first-page":"11","volume":"8","author":"RN Wickramasekara","year":"2019","unstructured":"Wickramasekara RN, Stessman HAF. Histone 4 lysine 20 methylation: a case for neurodevelopmental disease. Biology (Basel). 2019;8:11.","journal-title":"Biology (Basel)"},{"key":"3922_CR59","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41380-021-01060-x","volume":"27","author":"JJ Moffat","year":"2022","unstructured":"Moffat JJ, Smith AL, Jung EM, Ka M, Kim WY. Neurobiology of ARID1B haploinsufficiency related to neurodevelopmental and psychiatric disorders. Mol Psychiatry. 2022;27:476\u201389.","journal-title":"Mol Psychiatry"},{"key":"3922_CR60","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1101\/sqb.2014.79.024711","volume":"79","author":"LA Gunaydin","year":"2014","unstructured":"Gunaydin LA, Deisseroth K. Dopaminergic dynamics contributing to social behavior. Cold Spring Harb Symp Quant Biol. 2014;79:221\u20137.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"3922_CR61","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.neubiorev.2011.12.009","volume":"36","author":"D Kiser","year":"2012","unstructured":"Kiser D, Steemers B, Branchi I, Homberg JR. The reciprocal interaction between serotonin and social behaviour. Neurosci Biobehav Rev. 2012;36:786\u201398.","journal-title":"Neurosci Biobehav Rev"},{"key":"3922_CR62","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1111\/bph.13808","volume":"175","author":"LP Pellissier","year":"2018","unstructured":"Pellissier LP, Gandia J, Laboute T, Becker JAJ, Le Merrer J. mu opioid receptor, social behaviour and autism spectrum disorder: reward matters. Br J Pharmacol. 2018;175:2750\u201369.","journal-title":"Br J Pharmacol"},{"key":"3922_CR63","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.tics.2012.02.007","volume":"16","author":"C Chevallier","year":"2012","unstructured":"Chevallier C, Kohls G, Troiani V, Brodkin ES, Schultz RT. The social motivation theory of autism. Trends Cogn Sci. 2012;16:231\u20139.","journal-title":"Trends Cogn Sci"},{"key":"3922_CR64","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.cell.2014.05.017","volume":"157","author":"LA Gunaydin","year":"2014","unstructured":"Gunaydin LA, Grosenick L, Finkelstein JC, Kauvar IV, Fenno LE, Adhikari A, et al. Natural neural projection dynamics underlying social behavior. Cell. 2014;157:1535\u201351.","journal-title":"Cell"},{"key":"3922_CR65","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41593-021-00972-9","volume":"25","author":"C Solie","year":"2022","unstructured":"Solie C, Girard B, Righetti B, Tapparel M, Bellone C. VTA dopamine neuron activity encodes social interaction and promotes reinforcement learning through social prediction error. Nat Neurosci. 2022;25:86\u201397.","journal-title":"Nat Neurosci"},{"key":"3922_CR66","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJMoa013171","volume":"347","author":"JT McCracken","year":"2002","unstructured":"McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347:314\u201321.","journal-title":"N Engl J Med"},{"key":"3922_CR67","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1542\/peds.2008-3782","volume":"124","author":"R Owen","year":"2009","unstructured":"Owen R, Sikich L, Marcus RN, Corey-Lisle P, Manos G, McQuade RD, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics. 2009;124:1533\u201340.","journal-title":"Pediatrics"},{"key":"3922_CR68","doi-asserted-by":"publisher","first-page":"S124","DOI":"10.1542\/peds.2015-2851K","volume":"137","author":"LK Fung","year":"2016","unstructured":"Fung LK, Mahajan R, Nozzolillo A, Bernal P, Krasner A, Jo B, et al. Pharmacologic treatment of severe irritability and problem behaviors in autism: a systematic review and meta-analysis. Pediatrics. 2016;137:S124\u2013135.","journal-title":"Pediatrics"},{"key":"3922_CR69","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.euroneuro.2014.02.004","volume":"24","author":"S Gabriele","year":"2014","unstructured":"Gabriele S, Sacco R, Persico AM. Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis. Eur Neuropsychopharmacol. 2014;24:919\u201329.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3922_CR70","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/acps.12644","volume":"135","author":"K Jobski","year":"2017","unstructured":"Jobski K, Hofer J, Hoffmann F, Bachmann C. Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review. Acta Psychiatr Scand. 2017;135:8\u201328.","journal-title":"Acta Psychiatr Scand"},{"key":"3922_CR71","first-page":"CD004677","volume":"2013","author":"K Williams","year":"2013","unstructured":"Williams K, Brignell A, Randall M, Silove N, Hazell P. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2013;2013:CD004677.","journal-title":"Cochrane Database Syst Rev"},{"key":"3922_CR72","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1038\/npp.2014.59","volume":"39","author":"JA Becker","year":"2014","unstructured":"Becker JA, Clesse D, Spiegelhalter C, Schwab Y, Le Merrer J, Kieffer BL. Autistic-like syndrome in mu opioid receptor null mice is relieved by facilitated mGluR4 activity. Neuropsychopharmacology. 2014;39:2049\u201360.","journal-title":"Neuropsychopharmacology"},{"key":"3922_CR73","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1038\/npp.2011.117","volume":"36","author":"JP Burkett","year":"2011","unstructured":"Burkett JP, Spiegel LL, Inoue K, Murphy AZ, Young LJ. Activation of mu-opioid receptors in the dorsal striatum is necessary for adult social attachment in monogamous prairie voles. Neuropsychopharmacology. 2011;36:2200\u201310.","journal-title":"Neuropsychopharmacology"},{"key":"3922_CR74","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1126\/science.1095943","volume":"304","author":"A Moles","year":"2004","unstructured":"Moles A, Kieffer BL, D\u2019Amato FR. Deficit in attachment behavior in mice lacking the mu-opioid receptor gene. Science. 2004;304:1983\u20136.","journal-title":"Science"},{"key":"3922_CR75","first-page":"607","volume":"13","author":"J Panksepp","year":"1978","unstructured":"Panksepp J, Herman B, Conner R, Bishop P, Scott JP. The biology of social attachments: opiates alleviate separation distress. Biol Psychiatry. 1978;13:607\u201318.","journal-title":"Biol Psychiatry"},{"key":"3922_CR76","doi-asserted-by":"publisher","first-page":"104494","DOI":"10.1016\/j.neubiorev.2021.12.017","volume":"133","author":"GE DiCarlo","year":"2022","unstructured":"DiCarlo GE, Wallace MT. Modeling dopamine dysfunction in autism spectrum disorder: from invertebrates to vertebrates. Neurosci Biobehav Rev. 2022;133:104494.","journal-title":"Neurosci Biobehav Rev"},{"key":"3922_CR77","doi-asserted-by":"publisher","first-page":"700968","DOI":"10.3389\/fncir.2021.700968","volume":"15","author":"P Kosillo","year":"2021","unstructured":"Kosillo P, Bateup HS. Dopaminergic dysregulation in syndromic autism spectrum disorders: insights from genetic mouse models. Front Neural Circuits. 2021;15:700968.","journal-title":"Front Neural Circuits"},{"key":"3922_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-01174-w","volume":"11","author":"R Schalbroeck","year":"2021","unstructured":"Schalbroeck R, van Velden FHP, de Geus-Oei LF, Yaqub M, van Amelsvoort T, Booij J, et al. Striatal dopamine synthesis capacity in autism spectrum disorder and its relation with social defeat: an [(18)F]-FDOPA PET\/CT study. Transl Psychiatry. 2021;11:47.","journal-title":"Transl Psychiatry"},{"key":"3922_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-03088-3","volume":"14","author":"G Loseth","year":"2024","unstructured":"Loseth G, Trostheim M, Leknes S. Endogenous mu-opioid modulation of social connection in humans: a systematic review and meta-analysis. Transl Psychiatry. 2024;14:379.","journal-title":"Transl Psychiatry"},{"key":"3922_CR80","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neubiorev.2020.12.013","volume":"121","author":"IM Meier","year":"2021","unstructured":"Meier IM, van Honk J, Bos PA, Terburg D. A mu-opioid feedback model of human social behavior. Neurosci Biobehav Rev. 2021;121:250\u20138.","journal-title":"Neurosci Biobehav Rev"},{"key":"3922_CR81","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbr.2013.01.002","volume":"251","author":"D Oddi","year":"2013","unstructured":"Oddi D, Crusio WE, D\u2019Amato FR, Pietropaolo S. Monogenic mouse models of social dysfunction: implications for autism. Behav Brain Res. 2013;251:75\u201384.","journal-title":"Behav Brain Res"},{"key":"3922_CR82","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/scan\/nsz026","volume":"14","author":"TK Inagaki","year":"2019","unstructured":"Inagaki TK, Hazlett LI, Andreescu C. Naltrexone alters responses to social and physical warmth: implications for social bonding. Soc Cogn Affect Neurosci. 2019;14:471\u20139.","journal-title":"Soc Cogn Affect Neurosci"},{"key":"3922_CR83","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1037\/xge0000674","volume":"149","author":"TK Inagaki","year":"2020","unstructured":"Inagaki TK, Hazlett LI, Andreescu C. Opioids and social bonding: effect of naltrexone on feelings of social connection and ventral striatum activity to close others. J Exp Psychol Gen. 2020;149:732\u201345.","journal-title":"J Exp Psychol Gen"},{"key":"3922_CR84","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/scan\/nsw006","volume":"11","author":"TK Inagaki","year":"2016","unstructured":"Inagaki TK, Ray LA, Irwin MR, Way BM, Eisenberger NI. Opioids and social bonding: naltrexone reduces feelings of social connection. Soc Cogn Affect Neurosci. 2016;11:728\u201335.","journal-title":"Soc Cogn Affect Neurosci"},{"key":"3922_CR85","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.psyneuen.2016.08.022","volume":"74","author":"IM Meier","year":"2016","unstructured":"Meier IM, Bos PA, Hamilton K, Stein DJ, van Honk J, Malcolm-Smith S. Naltrexone increases negatively-valenced facial responses to happy faces in female participants. Psychoneuroendocrinology. 2016;74:65\u20138.","journal-title":"Psychoneuroendocrinology"},{"key":"3922_CR86","doi-asserted-by":"publisher","first-page":"1521016","DOI":"10.3389\/fnana.2024.1521016","volume":"18","author":"JA Galiza Soares","year":"2024","unstructured":"Galiza Soares JA, Sutley-Koury SN, Pomrenze MB, Tucciarone JM. Opioidergic tuning of social attachment: reciprocal relationship between social deprivation and opioid abuse. Front Neuroanat. 2024;18:1521016.","journal-title":"Front Neuroanat"},{"key":"3922_CR87","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/jir.12122","volume":"59","author":"A Roy","year":"2015","unstructured":"Roy A, Roy M, Deb S, Unwin G, Roy A. Are opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: a systematic review. J Intellect Disabil Res. 2015;59:293\u2013306.","journal-title":"J Intellect Disabil Res"},{"key":"3922_CR88","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fninf.2015.00007","volume":"9","author":"G Lopes","year":"2015","unstructured":"Lopes G, Bonacchi N, Frazao J, Neto JP, Atallah BV, Soares S, et al. Bonsai: an event-based framework for processing and controlling data streams. Front Neuroinform. 2015;9:7.","journal-title":"Front Neuroinform"},{"key":"3922_CR89","doi-asserted-by":"publisher","first-page":"W401","DOI":"10.1093\/nar\/gku410","volume":"42","author":"TG Montague","year":"2014","unstructured":"Montague TG, Cruz JM, Gagnon JA, Church GM, Valen E. CHOPCHOP: a CRISPR\/Cas9 and TALEN web tool for genome editing. Nucleic Acids Res. 2014;42:W401\u2013407.","journal-title":"Nucleic Acids Res"},{"key":"3922_CR90","doi-asserted-by":"publisher","first-page":"e98186","DOI":"10.1371\/journal.pone.0098186","volume":"9","author":"JA Gagnon","year":"2014","unstructured":"Gagnon JA, Valen E, Thyme SB, Huang P, Akhmetova L, Pauli A, et al. Efficient mutagenesis by Cas9 protein-mediated oligonucleotide insertion and large-scale assessment of single-guide RNAs. PLoS One. 2014;9:e98186.","journal-title":"PLoS One"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03922-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03922-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03922-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:05:26Z","timestamp":1791673526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03922-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":90,"alternative-id":["3922"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03922-8","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,10]]},"assertion":[{"value":"15 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"YG is the inventor of patent application 64\/150,081 which covers aspects of the discovery discussed in this manuscript. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All experiments were performed in accordance with the relevant guidelines and regulations. All zebrafish experiments were approved by the Institutional Animal Care and Use Committee at the University of Washington (4567-01) and were performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}